Neoplasia of Endocrine Tissues (posters)

MON-0311

ZIC1 Is a Putative Tumor Suppressor in Thyroid Cancer By Modulating Major Signaling Pathways and FOXO3a
Wei Qiang, Yuan Zhao, Qi Yang, Wei Liu, Haixia Guan, Si Qing Lv, Meiju Ji, Bingyin Shi and Peng Hou

MON-0312

Next-Generation Exome and Transcriptome Sequencing Identifies Possible Mechanisms of Human Mammary Epithelial Cell Immortalization
Justyna Kulpa, Radia Ouelaa Benslama, David Laperrière, Christine Tibolla and Sylvie Mader

MON-0313

Repressive Function of Tumor Suppressor p53 and Its Concerns in Prognosis of Breast Cancer Patients
Akitoshi Nakayama, Sawako Suzuki, Hidekazu Nagano, Naoko Hashimoto, Masanori Fujimoto, Eri Komai, Akina Shiga, Yutaka Suzuki, Sumio Sugano, Koutaro Yokote and Tomoaki Tanaka

MON-0314

Hyperglycemia-Induced Leptin Signaling Enhances Expression of Oncogenic microRNAs and microRNAs Governing Stem Cell Self-Renewal in Normal and Malignant Breast Epithelial Cells
Rebecca Lopez, Rene Roberts, Sushmita B Nandy, Ramadevi Subramani Reddy, Arunkumar Arumugam, Thiyagarajan Boopalan and Rajkumar Lakshmanaswamy

MON-0315

Topography of the Microenvironment Determines Cancer Cell Behaviour
John J Evans, Li Hui Tan, Peter H Sykes and Maan M Alkaisi

MON-0316

Mutant P53 Is a Key Determinant of Ovarian Cancer
Lisa K Mullany, Yi Ren, David C. Marciano, Kwong-Kwok Wong, Erin R King-Crane, Panagiotis Katsonis, Zhilin Liu, Olivier Lichtarge and JoAnne S Richards

MON-0317

Bile Acids Contribute to Gender-Biased Occurrence of Hepatocellular Carcinoma
Megan Emilie Patton, Sherwin Kelekar and Sayeepriyadarshini Anakk

MON-0319

Patient-Reported Satisfaction with Diarrhea Control Associated with Lanreotide Autogel/Depot (LAN) Treatment for Carcinoid Syndrome (CS) Is High in Gastroenteropancreatic Neuroendocrine Tumor (NET) Patients
Philippe Ruszniewski, Martyn E Caplin, Juan Valle, Catherine Lombard-Bohas, Graeme Poston, Petros Perros, Luboš Holubec, Gianfranco Delle Fave, Denis Smith, Patricia Niccoli, Pascal Maisonobe and Christine Massien

MON-0320

Lanreotide Autogel/Depot Shows Antitumor Effects in Patients with Metastatic Enteropancreatic NETs: Results of the Clarinet Extension Study
Martyn E Caplin, Philippe Ruszniewski, Marianne Ellen Pavel, Jaroslaw B Cwikla, Alexandria T Phan, Markus Raderer, Eva Sedlackova, Guillaume Cadiot, Lucy Wall, Guido Rindi, Alison Langley and Joelle Blumberg

MON-0321

IGSF1 As a New Modifier Gene Involved in Pituitary Adenoma Formation
Giampaolo Trivellin, Fabio R Faucz, Anelia Dafinova Horvath, Isaac Levy, Beata Bak, Paraskevi Xekouki, Eva Szarek, Evgenia Gourgari, Allison D Manning, Rodrigo Bertollo de Alexandre, Emmanouil Saloustros, Yu Sun, Maria V Nesterova, Jan M. Wit, Daniel J. Bernard and Constantine A Stratakis

MON-0322

Assessment of Genes Involved in Controlling CELL Proliferation and Apoptosis in the Molecular Pathogenesis of GH-Secreting Pituitary Adenoma
Renata Costa Camargo, Clarissa Silva Martins, Fabiano Pinto Saggioro, Luciano Neder, Helio Rubens Machado, Ayrton C. Moreira and Margaret De Castro

MON-0323

Serum 5-Hiaa - a Better Marker of Neuroendocrine Tumour Than Urine 5-Hiaa
Joanne Adaway, Rebecca Dobson, Jennifer S Walsh, Phillip Monaghan, Neil Devlin, Daniel Cuthbertson, Juan Valle and Brian G. Keevil

MON-0324

Biological Variability of Plasma 5-Hiaa
Joanne Adaway, Miguel Debono, John Newell-Price and Brian G. Keevil

MON-0325

Reference Range of Serum Calcitonin in Children
Tania Pilli, Maria G Castagna, Fabio Maino, Carla Fioravanti, Fausta Sestini, Letizia Pasqui, Carlo Scapellato, Renato Scarinci, Gabriele Cevenini, Alice Cannoni and Furio Pacini

MON-0326

Plasma Catecholamines - Sensitive Measurement By 2D-LC-MS/MS
Bingfang Yue, Tiedong Guo and Loan Nguyen